Hedge Fund - Rhenman & Partners Asset Management
Alexion Pharmaceuticals Inc. (ALXN)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2021 - Q2 (2021-06-30) | $0 | 0% | 0 | $171.66 |
| 2 | 2021 - Q1 (2021-03-31) | $6,116,000 | 0.42% | 40,000 | $154.69 |
| 3 | 2020 - Q4 (2020-12-31) | $18,749,000 | 1.52% | 120,000 | $128.50 |
| 4 | 2020 - Q3 (2020-09-30) | $25,175,000 | 2.23% | 220,000 | $107.88 |
| 5 | 2020 - Q2 (2020-06-30) | $21,326,000 | 2.3% | 190,000 | $106.17 |
| 6 | 2020 - Q1 (2020-03-31) | $14,366,000 | 2.01% | 160,000 | $98.14 |
| 7 | 2019 - Q4 (2019-12-31) | $15,284,000 | 1.67% | 141,319 | $106.96 |
| 8 | 2019 - Q3 (2019-09-30) | $24,221,000 | 3.03% | 247,303 | $112.72 |
| 9 | 2019 - Q2 (2019-06-30) | $26,591,000 | 2.92% | 203,017 | $128.89 |
| 10 | 2018 - Q4 (2018-12-31) | $22,435,000 | 2.56% | 230,429 | $118.20 |
| 11 | 2018 - Q3 (2018-09-30) | $33,825,000 | 3.38% | 243,329 | $125.44 |
| 12 | 2018 - Q2 (2018-06-30) | $23,820,000 | 2.43% | 191,863 | $116.87 |
| 13 | 2018 - Q1 (2018-03-31) | $24,729,000 | 3.04% | 221,863 | $119.53 |
| 14 | 2017 - Q4 (2017-12-31) | $18,161,000 | 2.45% | 151,863 | $121.78 |
| 15 | 2017 - Q3 (2017-09-30) | $23,148,000 | 2.95% | 165,000 | $135.86 |
| 16 | 2017 - Q2 (2017-06-30) | $18,737,000 | 2.69% | 154,000 | $116.39 |
| 17 | 2017 - Q1 (2017-03-31) | $13,543,000 | 2.14% | 111,702 | $128.92 |
| 18 | 2016 - Q4 (2016-12-31) | $11,220,000 | 2.15% | 91,702 | $122.36 |
| 19 | 2016 - Q3 (2016-09-30) | $19,814,963,000 | 3.14% | 161,702 | $128.72 |
| 20 | 2016 - Q2 (2016-06-30) | $26,047,000 | 4.62% | 223,082 | $141.88 |
| 21 | 2016 - Q1 (2016-03-31) | $16,846,000 | 3.34% | 121,000 | $146.83 |
| 22 | 2015 - Q4 (2015-12-31) | $19,075,000 | 2.88% | 100,000 | $174.68 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
2.0000:1.0000 on 2011-05-23